Clinical Trials Directory

Trials / Completed

CompletedNCT03274167

Efficacy of Gabapentin in Alcohol Dependency Treatment

Efficacy of Gabapentin in Alcohol Dependency Treatment: a Double-blinded Randomized Placebo-controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to study the effect of gabapentin on the number of alcohol drinking days and heavy drinking days in the Thai clinical alcohol-dependent population by using the double-blinded randomized controlled approach. One-hundred and twelve individuals with alcohol dependence were randomly assigned equally into two groups including treatment with gabapentin and placebo. Thirty-four patients (30.3%) completed the study protocol, i.e. treatment with gabapentin at least 300 mg per day or placebo orally once a day for twelve weeks. Pattern of alcohol drinking were obtained from the timelime followback. Drinking behaviors were compared between the two groups by poisson repeated measures model.

Conditions

Interventions

TypeNameDescription
DRUGGabapentin 300mg
DRUGPlacebo oral capsule

Timeline

Start date
2012-01-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2017-09-06
Last updated
2017-09-06

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03274167. Inclusion in this directory is not an endorsement.